<DOC>
	<DOCNO>NCT01081574</DOCNO>
	<brief_summary>The conduct clinical trial aim determine suitable dose regimen child different age group , secondarily assess safety tolerability bilastine paediatric population subset .</brief_summary>
	<brief_title>Pharmacokinetic Study Bilastine Children From 2 &lt; 12 Years Age With Either Allergic Rhinoconjunctivitis ( AR ) Chronic Urticaria ( CU )</brief_title>
	<detailed_description>The objective study ass pharmacokinetics bilastine child ( age 2 &lt; 12 year ) allergic rhinoconjunctivitis ( seasonal allergic rhinitis [ SAR ] and/or perennial allergic rhinitis [ PAR ] ) chronic urticaria ( CU ) order ascertain systemic exposure attain dose 10 mg/QD lower comparable achieve adult adolescent administer dose 20 mg/QD . Additional objective describe safety tolerability repeat administration bilastine child AR CU .</detailed_description>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>1 . Either sex age ≥ 2 &lt; 12 year age . Female subject must child bear potential . 2 . Height weight within majority range ( e.g. , 25th 75th percentile ) subject 's age sex provide national table . 3 . Documented history SAR/PAR CU time inclusion . Subjects must symptomatic screen judged investigator . 4 . A documented positive skin prick test IgE test ( RAST ) least one seasonal perennial allergen child AR obtain within 12 month prior inclusion . 5 . Excepting AR CU , judge general good health base medical history , physical examination clinical laboratory test , QTc duration ECG record screen within normal range ( ≤ 440 msec ) . 6 . Written inform consent sign legal representative minor ( his/her parent ( ) person legally appoint different parent ( ) ) , applicable , assent sign child , accord local regulation . 1 . Female subject childbearing potential . If menarche occur study enrolment dose period , subject discontinue treatment follow safety per protocol . Occurrence menarche course study always document . 2 . Intake another investigational medication another clinical study within 30 day prior first study drug intake . 3 . Clinically significant ECG abnormality judge investigator ( e.g. , WolffParkinsonWhite [ WPW ] syndrome , long QT syndrome ) . 4 . Known allergy/hypersensitivity study drug inactive ingredient . 5 . Any clinical condition circumstance opinion investigator would make subject unsuitable study ( e.g. , hepatic impairment , renal impairment , mental impairment , cardiac disease ) . 6 . Subjects know positive Hepatitis B surface antigen ( Hbs Ag ) , Hepatitis C antibody know human immunodeficiency virus ( HIV ) positive . No testing require study . 7 . Subjects expect take study period take following medication prior inclusion study comply specified wash period 7 day unless otherwise note : Oral corticosteroid . Oral antihistamine : loratadine , desloratadine , fexofenadine . Antileukotrienes Amoxicillin , benzylpenicillin , macrolide antibiotic imidazolic antifungal ( systemic ) Omeprazol Aspirin , ibuprofen Carbamazepine St. John 's Wort ( 15 day ) 8 . Hypersensitivity H1 antihistamines benzimidazoles . 9 . Ingestion citrus fruit cranberry fruit juice well know PgP organic anion transporter polypeptide ( OATP ) inhibitor , inducer , substrate ( see Appendix C ) within 7 day prior first dose study medication . 10 . Mentally disabled minor Minors official order institutionalise ( e.g. , orphanage ) must exclude participation . 11 . Minors explicitly refuse take part study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Seasonal Allergic Rhinitis</keyword>
	<keyword>Perennial Allergic Rhinitis</keyword>
	<keyword>Urticaria</keyword>
	<keyword>Chronic Idiopathic Urticaria</keyword>
	<keyword>Allergy</keyword>
	<keyword>Sneezing</keyword>
	<keyword>Nasal Itching</keyword>
	<keyword>Rhinorrhea</keyword>
	<keyword>Nasal Congestion</keyword>
	<keyword>Wheals</keyword>
	<keyword>Hives</keyword>
	<keyword>Skin itching</keyword>
	<keyword>Flare</keyword>
	<keyword>Erythema</keyword>
</DOC>